Cardiovascular risk in ADT recipients: does the type of ADT matter?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- September 2024
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Androgen Antagonists (MeSH)
- Cardiovascular Diseases (MeSH)
- Heart Disease Risk Factors (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Prostatic Neoplasms (MeSH)
- Risk Factors (MeSH)
- Urology & Nephrology (Science Metrix)